Radiation Therapy Approaches for People With Prostate Cancer
About this study
The purpose of the study is to explore the best ways of giving radiation therapy to balance cancer control and treatment side effects.
- Condition
- Prostate Cancer Patients, Non-metastatic Prostate Cancer, High Risk Prostate Cancer
- Tested
- Standard of Care HDR Brachytherapy, SBRT
- Sponsor
- Memorial Sloan Kettering Cancer Center
Who can join
- Age
- Not specified
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 4
- Study condition: Prostate Cancer Patients, Non-metastatic Prostate Cancer, High Risk Prostate Cancer
- Non-metastatic prostate cancer.
- Classified as unfavorable intermediate-, high-, or very high-risk prostate cancer according to NCCN risk stratification guidelines. (Note: cT3a or T3b by MRI or PSMA PET allowed)
- Considered by the treating radiation oncologist as a suitable candidate for both HDR brachytherapy boost and SBRT
Where
7 sites, 7 recruiting
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities)
Commack, New York, United States
Memorial Sloan Kettering at Westchester (Limited Protocol Activities)
Harrison, New York, United States
Memorial Sloan Kettering at Monmouth (Limited Protocol Activities)
Middletown, New Jersey, United States
Memorial Sloan Kettering at Bergen (Limited Protocol Activities)
Montvale, New Jersey, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activites)
New York, New York, United States
and 1 more site on ClinicalTrials.gov
Contact
-
Daniel Gorovets, MD
212-639-3983 gorovetd@mskcc.org
-
Himanshu Nagar, MD
212-639-6478 nagarh1@mskcc.org
Potential match only. Final eligibility is determined by the study team.